Friday, March 20, 2015

Aurobindo has acetaminophen and codeine 300 mg/30 mg tablets on back order and the company cannot es


About Us What We Do Strategic Plan Our Leadership Our History New Logo and Tagline Awards Nominations/Elections ASHP Careers For the Press Member Center Join/Renew Manage My Account Membership Benefits Sections and Forums InterSections FAQs Education Continuing pac Education eLearning Home Study Activities Women in Leadership pac Webinars Specialty Certifications Traineeships Practice & Policy Policies & Guidelines Resource Centers House of Delegates PPMI Events Meetings & Conferences Calendar of Events Get Involved in a Meeting For Presenters Advocacy Advocacy Agenda Federal Issues State Advocacy Policy Analysis & Alerts Grassroots Network ASHP PAC News Pharmacy News News Capsules Press Releases ASHP in the News RSS Feeds Photo Gallery Residency
Publications Meetings eLearning eBooks eBooks - My Library For Authors Help & Support Select Page Home About Us     What We Do     Strategic Plan     Our Leadership     New Logo and Tagline     Our History     Awards     Nominations and Elections     ASHP Careers     For the Press Member Center     Join/Renew     Manage My Account     Membership Benefits     Sections and Forums     On Demand Webinars     InterSections     FAQs Education     Continuing Education     eLearning     Home Study Activities     Webinars     Specialty Certifications     Traineeships Practice & Policy     Policies pac & Guidelines     Resource Centers     House of Delegates     PPMI Events     Meetings & Conferences     Calendar of Events     Get Involved in a Meeting     For Presenters Advocacy     Advocacy Agenda     Federal Issues     State Advocacy     Policy pac Analysis and Alerts     Grassroots Network     ASHP PAC News     Pharmacy News     News Capsules     Press Releases     ASHP in the News     RSS Feeds     Photo Gallery Accreditation     Residency Accreditation     Technician Accreditation     Residency Directory     Technician Training Directory     Additional Resources     Complaints pac     Contact Us Store     Publications     eBooks     For Authors pac     Help & Support
Acetaminophen and codeine phosphate tablets, Aurobindo 300 mg/30 mg, 100 count (NDC 13170-0059-01) 300 mg/30 mg, 1000 count (NDC 13107-0059-99) Acetaminophen and codeine phosphate tablets, Mallinckrodt 300 mg/30 mg, 20 count (NDC 00406-0484-20) 300 mg/30 mg, 30 count (NDC 00406-0484-03) 300 mg/30 mg, 50 count (NDC 00406-0484-50) 300 mg/30 mg, 100 count unit-dose (NDC 00406-0484-62) 300 mg/30 mg, 100 count (NDC 00406-0484-01) pac 300 mg/30 mg, 1000 count (NDC 00406-0484-10) pac Acetaminophen and codeine phosphate tablets, Teva 300 mg/30 mg, 1000 count (NDC 00093-0150-10) pac Tylenol with Codeine, Janssen 300 mg/30 mg, 100 count (NDC 50458-0513-60) Reason for the Shortage
Mallinckrodt states the shortage is due to production delays and increased demand. Aurobindo and Teva could not provide a reason pac for the shortage. Qualitest will not provide shortage information pac for any of their products because they consider the information to be proprietary pac . Available Products pac
Acetaminophen and codeine phosphate tablets, Amneal 300 mg/30 mg, 100 count (NDC 65162-0033-10) 300 mg/30 mg, 1000 count (NDC 65162-0033-11) Acetaminophen and codeine phosphate tablets, Mylan Institutional 300 mg/30 mg, 100 count unit-dose (NDC 51079-0161-20) 300 mg/30 mg, 100 count unit-dose (NDC 51079-0161-21) Acetaminophen and codeine phosphate tablets, Teva 300 mg/30 mg, 100 count (NDC 00093-0150-01) Tylenol with Codeine, Janssen 300 mg/30 mg, 1000 count (NDC 50458-0513-80) Estimated Resupply Dates
Aurobindo has acetaminophen and codeine 300 mg/30 mg tablets on back order and the company cannot estimate a release date. Mallinckrodt has temporarily discontinued all acetaminophen and codeine 300 mg/30 mg tablet pac presentations and does not expect product to be available until April 2015 . Teva has acetaminophen and codeine 300 mg/30 mg tablets in 1000 count on back order and the company estimates a release date in

No comments:

Post a Comment